David Neil Hayes
Fondatore presso GeneCentric Therapeutics, Inc.
Profilo
David Neil Hayes is the founder of GeneCentric Therapeutics, Inc. which was founded in 2011.
He held the title of Director at the company.
Currently, he is the Director-Clinical Bioinformatics at North Carolina Cancer Hospital.
Dr. Hayes has an undergraduate degree from Davidson College, a graduate degree from Harvard T.H.
Chan School of Public Health, and a doctorate from The University of North Carolina at Charlotte.
Posizioni attive di David Neil Hayes
| Società | Posizione | Inizio |
|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Fondatore | 01/01/2011 |
North Carolina Cancer Hospital
 North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Corporate Officer/Principal | - |
Formazione di David Neil Hayes
| The University of North Carolina at Charlotte | Doctorate Degree |
| Davidson College | Undergraduate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
North Carolina Cancer Hospital
North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Health Services |
- Borsa valori
- Insiders
- David Neil Hayes
